VIB-RUG Department of Molecular Biomedical Research

Molecular ImmunoBiotechnology Unit













 Our mission is to develop technology based on the creation

 and use of molecules modifying the immune system, in order to investigate new opportunities in immunotherapy.

Our main project involves the evaluation of an improved manifold for the creation of multivalent, multispecific or multifunctional antibody derivatives, in order to obtain recombinant antibody-based anti-cancer reagents. The ultimate goal is to evaluate new opportunities to immunotherapeutic approaches using recombinant antibody derivatives. 

We also develop technology to further improve the chance on successful heterologous expression in E. coli, especially cytokines.


Here you will find some  background information about developed technology


These pages are best viewed with MS Internet Explorer 5 or higher  

Welcome visitor  

Site update 25/08/2003



Research projects


After eight

Check out 

links to:

MABs on the market
Antibody Companies
Immune Therapy Companies
Custom protein expression and purification
Biotech in Flanders
Flanders Universities
Flanders Biotech Policy


2002 Webmaster